1. Home
  2. EVI vs MDWD Comparison

EVI vs MDWD Comparison

Compare EVI & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EVI Industries Inc.

EVI

EVI Industries Inc.

SELL

Current Price

$20.01

Market Cap

204.6M

ML Signal

SELL

Logo MediWound Ltd.

MDWD

MediWound Ltd.

SELL

Current Price

$13.53

Market Cap

202.6M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
EVI
MDWD
Founded
1959
2000
Country
United States
Israel
Employees
N/A
N/A
Industry
Other Consumer Services
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
204.6M
202.6M
IPO Year
1995
2013

Fundamental Metrics

Financial Performance
Metric
EVI
MDWD
Price
$20.01
$13.53
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
★ $29.67
AVG Volume (30 Days)
92.8K
★ 139.7K
Earning Date
11-09-2026
11-12-2026
Dividend Yield
★ 1.58%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.24
N/A
Revenue
★ $389,830,000.00
N/A
Revenue This Year
$8.40
$32.97
Revenue Next Year
$4.71
$39.75
P/E Ratio
$87.00
★ N/A
Revenue Growth
★ 10.26
N/A
52 Week Low
$12.75
$11.80
52 Week High
$27.00
$19.70

Technical Indicators

Market Signals
Indicator
EVI
MDWD
Relative Strength Index (RSI) 44.93 51.23
Support Level $19.93 $12.16
Resistance Level $21.37 $14.52
Average True Range (ATR) 1.50 0.67
MACD -0.28 -0.02
Stochastic Oscillator 6.35 45.62

Price Performance

Historical Comparison
EVI
MDWD

About EVI EVI Industries Inc.

EVI Industries Inc is a value-added distributor and service provider in the commercial laundry industry. It sells and leases commercial laundry equipment, specializing in washing, drying, finishing, material handling, water heating, power generation, and water reuse applications. The company supports its equipment offerings with installation, maintenance, and repair services through a large network of trained technicians. It serves a wide range of customers, including commercial, industrial, institutional, government, and retail sectors. Geographically, the company serves various countries including United States, Canada, the Caribbean, and Latin America.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid, is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: